Abstract: The disclosure provides a method for evaluating whether an individual with cancer is suitable for being administered with anti-cancer drugs. Wherein the anti-cancer drug is a CDK inhibitor. The method includes the following steps: (1) detecting a copy number of a first gene and a copy number of a second gene from an in vitro sample of the individual with the cancer to obtain a copy number variation (CNV) of the first gene and a copy number variation (CNV) of the second gene; (2) calculating a copy number variation ratio (CNV ratio) between the copy number variation (CNV) of the first gene and the copy number variation (CNV) of the second gene, wherein the first gene encodes a cyclin and the second gene encodes a cyclin dependent kinase inhibitor (CDKN); and (3) determining whether the individual with the cancer is suitable for being administered with the CDK inhibitor according to the CNV ratio.

Abstract: The present invention provides a human nasopharyngeal carcinoma cell line derived from a patient derived xenograft. The novel human nasopharyngeal carcinoma cells comprise human herpesvirus 4 and specific short tandem repeat loci. Also provided are cellular composition comprising the novel nasopharyngeal carcinoma cell line described herein and the use of the novel nasopharyngeal carcinoma cell line for detecting a potential therapeutic agent.

Abstract: A camera device includes an outer cap, a lens, a circuit board, and a dustproof sheet. The outer cap includes an axle hole, a first end, and a second end axially opposite to the first end. The lens is disposed on the first end of the outer cap. The circuit board is disposed on the second end of the outer cap. The circuit board includes an inner surface located in the axle hole. The inner surface has an optical sensing area and a non-optical sensing area. An optical sensing module is disposed on the optical sensing area to correspond to the lens. The dustproof sheet is disposed in the axle hole of the outer cap. The dustproof sheet covers the non-optical sensing area of the inner surface of the circuit board.

Abstract: The disclosure provides a method for evaluating whether an individual with cancer is suitable for being administered with anti-cancer drugs. Wherein the anti-cancer drug is a CDK inhibitor. The method includes the following steps: (1) detecting a copy number of a first gene and a copy number of a second gene from an in vitro sample of the individual with the cancer to obtain a copy number variation (CNV) of the first gene and a copy number variation (CNV) of the second gene; (2) calculating a copy number variation ratio (CNV ratio) between the copy number variation (CNV) of the first gene and the copy number variation (CNV) of the second gene, wherein the first gene encodes a cyclin and the second gene encodes a cyclin dependent kinase inhibitor (CDKN); and (3) determining whether the individual with the cancer is suitable for being administered with the CDK inhibitor according to the CNV ratio.

Abstract: Methods for treating androgen receptor related diseases and suppressing androgen receptor related function by administering an effective amount of minoxidil are provided. Methods for treating or prophylactically treating acne by administering an effective amount of minoxidil are also provided. An anti-acne medication is optionally administered to treat or prophylactically treat acne.

Abstract: Methods for treating androgen receptor related diseases and suppressing androgen receptor related function by administering an effective amount of minoxidil are provided. Methods for treating or prophylactically treating acne by administering an effective amount of minoxidil are also provided. An anti-acne medication is optionally administered to treat or prophylactically treat acne.

Abstract: A power adapter includes an insulating casing including an enclosing wall and defining a sealing chamber therein, a power transforming unit disposed in the sealing chamber, and a heat sink device including a heat dispersing member supported within the sealing chamber at a position between the enclosing wall and the power transforming unit to thermal-communicate with the power transforming unit, wherein the heat dispersing member has an air insulating cavity formed above the power transforming unit in such a manner that when the power transforming unit generates heat for heating up air within the air insulating cavity, the heat is diffused throughout the air insulating cavity so as to evenly disperse on the enclosing wall of the insulating casing.

Abstract: A power adapter includes an insulating casing including an enclosing wall and defining a sealing chamber therein, a power transforming unit disposed in the sealing chamber, and a heat sink device including a heat dispersing member supported within the sealing chamber at a position between the enclosing wall and the power transforming unit to thermal-communicate with the power transforming unit, wherein the heat dispersing member has an air insulating cavity formed above the power transforming unit in such a manner that when the power transforming unit generates heat for heating up air within the air insulating cavity, the heat is diffused throughout the air insulating cavity so as to evenly disperse on the enclosing wall of the insulating casing.